Prognostic impact of new‐onset atrial fibrillation in myocardial infarction with and without improved ejection fraction

Abstract Aims Improvement in left ventricular ejection fraction (impEF) often presents in contemporary acute myocardial infarction (AMI) patients. New‐onset atrial fibrillation (NOAF) during AMI is an important predictor of subsequential heart failure (HF), while its impact on the trajectory of post...

Full description

Saved in:
Bibliographic Details
Main Authors: Jiachen Luo, Xiaoming Qin, Xingxu Zhang, Yiwei Zhang, Yuan Fang, Wentao Shi, Baoxin Liu, Yidong Wei, the NOAFCAMI‐SH Registry Investigators
Format: Article
Language:English
Published: Wiley 2024-12-01
Series:ESC Heart Failure
Subjects:
Online Access:https://doi.org/10.1002/ehf2.14956
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1846128429471105024
author Jiachen Luo
Xiaoming Qin
Xingxu Zhang
Yiwei Zhang
Yuan Fang
Wentao Shi
Baoxin Liu
Yidong Wei
the NOAFCAMI‐SH Registry Investigators
author_facet Jiachen Luo
Xiaoming Qin
Xingxu Zhang
Yiwei Zhang
Yuan Fang
Wentao Shi
Baoxin Liu
Yidong Wei
the NOAFCAMI‐SH Registry Investigators
author_sort Jiachen Luo
collection DOAJ
description Abstract Aims Improvement in left ventricular ejection fraction (impEF) often presents in contemporary acute myocardial infarction (AMI) patients. New‐onset atrial fibrillation (NOAF) during AMI is an important predictor of subsequential heart failure (HF), while its impact on the trajectory of post‐MI left ventricular ejection fraction (LVEF) and prognostic implication in patients with and without impEF remains undetermined. We aimed to investigate the prognostic impacts of NOAF in AMI patients with and without impEF. Methods and results Consecutive AMI patients without a prior history of AF between February 2014 and March 2018 with baseline LVEF ≤ 40% and had ≥1 LVEF measurement after baseline were included. ImpEF was defined as a baseline LVEF ≤ 40% and a re‐evaluation showed both LVEF > 40% and an absolute increase of LVEF ≥ 10%. Persistently reduced EF (prEF) was defined as the second measurement of LVEF either ≤40% or an absolute increase of LVEF < 10%. The primary endpoint was a major adverse cardiac event (MACE) that was composed of cardiovascular death and HF hospitalization. Cox regression analysis and competing risk analysis were performed to assess the association of post‐MI NOAF with MACE. Among 293 patients (mean age: 66.6 ± 11.3 years, 79.2% of males), 145 (49.5%) had impEF and 67 (22.9%) developed NOAF. Higher heart rate (odds ratio [OR]: 0.84, 95% confidence interval [CI]: 0.73–0.97; P = 0.015), prior MI (OR: 0.25, 95% CI: 0.09–0.69; P = 0.008), and STEMI (OR: 0.40, 95% CI: 0.21–0.77; P = 0.006) were independent predictors of post‐MI impEF. Within up to 5 years of follow‐up, there were 22 (15.2%) and 53 (35.8%) MACE in patients with impEF and prEF, respectively. NOAF was an independent predictor of MACE in patients with impEF (hazard ratio [HR]: 7.34, 95% CI: 2.49–21.59; P < 0.001) but not in those with prEF (HR: 0.78, 95% CI: 0.39–1.55; P = 0.483) after multivariable adjustment. Similar results were obtained when accounting for the competing risk of all‐cause death (subdistribution HR and 95% CIs in impEF and prEF were 6.47 [2.32–18.09] and 0.79 [0.39–1.61], respectively). Conclusions The NOAF was associated with an increased risk of cardiovascular outcomes in AMI patients with impEF.
format Article
id doaj-art-da60f62817324aa3b32e75ccac571cbd
institution Kabale University
issn 2055-5822
language English
publishDate 2024-12-01
publisher Wiley
record_format Article
series ESC Heart Failure
spelling doaj-art-da60f62817324aa3b32e75ccac571cbd2024-12-11T01:56:59ZengWileyESC Heart Failure2055-58222024-12-011163713372210.1002/ehf2.14956Prognostic impact of new‐onset atrial fibrillation in myocardial infarction with and without improved ejection fractionJiachen Luo0Xiaoming Qin1Xingxu Zhang2Yiwei Zhang3Yuan Fang4Wentao Shi5Baoxin Liu6Yidong Wei7the NOAFCAMI‐SH Registry Investigators8Department of Cardiology, Shanghai Tenth People's Hospital Tongji University School of Medicine Shanghai ChinaDepartment of Cardiology, Shanghai Tenth People's Hospital Tongji University School of Medicine Shanghai ChinaDepartment of Cardiology, Shanghai Tenth People's Hospital Tongji University School of Medicine Shanghai ChinaDepartment of Cardiology, Shanghai Tenth People's Hospital Tongji University School of Medicine Shanghai ChinaDepartment of Cardiology, Shanghai Tenth People's Hospital Tongji University School of Medicine Shanghai ChinaDepartment of Cardiology, Shanghai Tenth People's Hospital Tongji University School of Medicine Shanghai ChinaDepartment of Cardiology, Shanghai Tenth People's Hospital Tongji University School of Medicine Shanghai ChinaDepartment of Cardiology, Shanghai Tenth People's Hospital Tongji University School of Medicine Shanghai ChinaDepartment of Cardiology, Shanghai Tenth People's Hospital Tongji University School of Medicine Shanghai ChinaAbstract Aims Improvement in left ventricular ejection fraction (impEF) often presents in contemporary acute myocardial infarction (AMI) patients. New‐onset atrial fibrillation (NOAF) during AMI is an important predictor of subsequential heart failure (HF), while its impact on the trajectory of post‐MI left ventricular ejection fraction (LVEF) and prognostic implication in patients with and without impEF remains undetermined. We aimed to investigate the prognostic impacts of NOAF in AMI patients with and without impEF. Methods and results Consecutive AMI patients without a prior history of AF between February 2014 and March 2018 with baseline LVEF ≤ 40% and had ≥1 LVEF measurement after baseline were included. ImpEF was defined as a baseline LVEF ≤ 40% and a re‐evaluation showed both LVEF > 40% and an absolute increase of LVEF ≥ 10%. Persistently reduced EF (prEF) was defined as the second measurement of LVEF either ≤40% or an absolute increase of LVEF < 10%. The primary endpoint was a major adverse cardiac event (MACE) that was composed of cardiovascular death and HF hospitalization. Cox regression analysis and competing risk analysis were performed to assess the association of post‐MI NOAF with MACE. Among 293 patients (mean age: 66.6 ± 11.3 years, 79.2% of males), 145 (49.5%) had impEF and 67 (22.9%) developed NOAF. Higher heart rate (odds ratio [OR]: 0.84, 95% confidence interval [CI]: 0.73–0.97; P = 0.015), prior MI (OR: 0.25, 95% CI: 0.09–0.69; P = 0.008), and STEMI (OR: 0.40, 95% CI: 0.21–0.77; P = 0.006) were independent predictors of post‐MI impEF. Within up to 5 years of follow‐up, there were 22 (15.2%) and 53 (35.8%) MACE in patients with impEF and prEF, respectively. NOAF was an independent predictor of MACE in patients with impEF (hazard ratio [HR]: 7.34, 95% CI: 2.49–21.59; P < 0.001) but not in those with prEF (HR: 0.78, 95% CI: 0.39–1.55; P = 0.483) after multivariable adjustment. Similar results were obtained when accounting for the competing risk of all‐cause death (subdistribution HR and 95% CIs in impEF and prEF were 6.47 [2.32–18.09] and 0.79 [0.39–1.61], respectively). Conclusions The NOAF was associated with an increased risk of cardiovascular outcomes in AMI patients with impEF.https://doi.org/10.1002/ehf2.14956Atrial fibrillationCompeting risk analysisImproved ejection fractionMyocardial infarction
spellingShingle Jiachen Luo
Xiaoming Qin
Xingxu Zhang
Yiwei Zhang
Yuan Fang
Wentao Shi
Baoxin Liu
Yidong Wei
the NOAFCAMI‐SH Registry Investigators
Prognostic impact of new‐onset atrial fibrillation in myocardial infarction with and without improved ejection fraction
ESC Heart Failure
Atrial fibrillation
Competing risk analysis
Improved ejection fraction
Myocardial infarction
title Prognostic impact of new‐onset atrial fibrillation in myocardial infarction with and without improved ejection fraction
title_full Prognostic impact of new‐onset atrial fibrillation in myocardial infarction with and without improved ejection fraction
title_fullStr Prognostic impact of new‐onset atrial fibrillation in myocardial infarction with and without improved ejection fraction
title_full_unstemmed Prognostic impact of new‐onset atrial fibrillation in myocardial infarction with and without improved ejection fraction
title_short Prognostic impact of new‐onset atrial fibrillation in myocardial infarction with and without improved ejection fraction
title_sort prognostic impact of new onset atrial fibrillation in myocardial infarction with and without improved ejection fraction
topic Atrial fibrillation
Competing risk analysis
Improved ejection fraction
Myocardial infarction
url https://doi.org/10.1002/ehf2.14956
work_keys_str_mv AT jiachenluo prognosticimpactofnewonsetatrialfibrillationinmyocardialinfarctionwithandwithoutimprovedejectionfraction
AT xiaomingqin prognosticimpactofnewonsetatrialfibrillationinmyocardialinfarctionwithandwithoutimprovedejectionfraction
AT xingxuzhang prognosticimpactofnewonsetatrialfibrillationinmyocardialinfarctionwithandwithoutimprovedejectionfraction
AT yiweizhang prognosticimpactofnewonsetatrialfibrillationinmyocardialinfarctionwithandwithoutimprovedejectionfraction
AT yuanfang prognosticimpactofnewonsetatrialfibrillationinmyocardialinfarctionwithandwithoutimprovedejectionfraction
AT wentaoshi prognosticimpactofnewonsetatrialfibrillationinmyocardialinfarctionwithandwithoutimprovedejectionfraction
AT baoxinliu prognosticimpactofnewonsetatrialfibrillationinmyocardialinfarctionwithandwithoutimprovedejectionfraction
AT yidongwei prognosticimpactofnewonsetatrialfibrillationinmyocardialinfarctionwithandwithoutimprovedejectionfraction
AT thenoafcamishregistryinvestigators prognosticimpactofnewonsetatrialfibrillationinmyocardialinfarctionwithandwithoutimprovedejectionfraction